DCT
1:20-cv-00019
Boehringer Ingelheim Pharma Inc v. Mylan Pharma Inc
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (07/02/21)
Patent Owner
NPE (W)
SourcePACER
Nature of Suit830 Patent
CourtN.D. West Virginia
Judge | Period | PO Win Rate |
|---|---|---|
09/15/21 - 11/24/25 | -- | |
08/16/21 - 09/15/21 | 50% | |
06/15/20 - 08/16/21 | 58% |
Plaintiff
Party
Attorney
Defendant
Party
Attorney